A new FDA-approved blood test designed to detect colon cancer earlier is now available in North Texas. An estimated 154,270 people in the U.S. will be diagnosed with colorectal cancer this year.

TheWizards APT group uses SLAAC spoofing to perform adversary-in-the-middle attacks ESET researchers analyzed Spellbinder, a lateral movement tool used to perform adversary-in-the-middle attacks ...

A new FDA-approved blood test designed to detect colon cancer earlier is now available in North Texas.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines the implications that ...